FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

J A A Hoogkamp-Korstanje

Research Profile

Living Beings

Geographic Areas

Netherlands

Disorders

Procedures

Chemicals & Drugs

Objects

Intensive Care Units

Phenomena

DNA Fingerprinting

Physiology

Anatomy

Feces

Concepts & Ideas

Sensitivity and Specificity

Co-author Network

Publications

TOP 3
P D Croughs; J A A Hoogkamp-Korstanje; B Li; Ellen E Stobberingh
Thirteen years of antibiotic susceptibility surveillance of Pseudomonas aeruginosa from intensive care units and urology services in the Netherlands.
C F M van der Donk; P S Beisser; J A A Hoogkamp-Korstanje; C A Bruggeman; Ellen E Stobberingh
A 12 year (1998-2009) antibiotic resistance surveillance of Klebsiella pneumoniae collected from intensive care and urology patients in 14 Dutch hospitals.
M I A Rijnders; Ruud H Deurenberg; M L L Boumans; J A A Hoogkamp-Korstanje; P S Beisser; Ellen E Stobberingh
Population structure of Staphylococcus aureus strains isolated from intensive care unit patients in the netherlands over an 11-year period (1996 to 2006).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of J A A Hoogkamp-Korstanje (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: P D Croughs; J A A Hoogkamp-Korstanje; B Li; Ellen E Stobberingh
Thirteen years of antibiotic susceptibility surveillance of Pseudomonas aeruginosa from intensive care units and urology services in the Netherlands.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2013;32(2):283-8.
2011: C F M van der Donk; P S Beisser; J A A Hoogkamp-Korstanje; C A Bruggeman; Ellen E Stobberingh
A 12 year (1998-2009) antibiotic resistance surveillance of Klebsiella pneumoniae collected from intensive care and urology patients in 14 Dutch hospitals.
The Journal of antimicrobial chemotherapy 2011;66(4):855-8.
2009: M I A Rijnders; Ruud H Deurenberg; M L L Boumans; J A A Hoogkamp-Korstanje; P S Beisser; Ellen E Stobberingh
Population structure of Staphylococcus aureus strains isolated from intensive care unit patients in the netherlands over an 11-year period (1996 to 2006).
Journal of clinical microbiology 2009;47(12):4090-5.
2009: M I A Rijnders; Ruud H Deurenberg; M L L Boumans; J A A Hoogkamp-Korstanje; P S Beisser; Ellen E Stobberingh
Flucloxacillin, still the empirical choice for putative Staphylococcus aureus infections in intensive care units in the Netherlands.
The Journal of antimicrobial chemotherapy 2009;64(5):1029-34.
2008: Sita Nys; Peter H Terporten; J A A Hoogkamp-Korstanje; Ellen E Stobberingh
Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005).
The Journal of antimicrobial chemotherapy 2008;62(1):126-32.
2008: G J Oudhuis; Annelies Verbon; J A A Hoogkamp-Korstanje; Ellen E Stobberingh
Antimicrobial resistance in Escherichia coli and Pseudomonas aeruginosa from Intensive Care Units in The Netherlands, 1998-2005.
International journal of antimicrobial agents 2008;31(1):58-63.
2004: F Bosma; J M Deckers-Kocken; Siebold S N de Graaf; Tanja Schülin; Willem J G Melchers; J A A Hoogkamp-Korstanje
Mycobacterium reverse hybridization line-probe assay used to diagnose disseminated Mycobacterium haemophilum infection in a child with acute lymphoblastic leukemia.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2004;23(4):345-7.
2003: J A A Hoogkamp-Korstanje; J Roelofs-Willemse
Antimicrobial resistance in Gram-negative bacteria from Intensive Care Units and Urology Services. A nationwide study in The Netherlands 1995-2000.
International journal of antimicrobial agents 2003;21(6):547-56.
2003: J A A Hoogkamp-Korstanje
[Nutrition and health--infections caused by food].
Nederlands tijdschrift voor geneeskunde 2003;147(13):590-4.
2001: J A A Hoogkamp-Korstanje
[Antibiotic resistance: recommendations from the Advisory Council for Health Research].
Nederlands tijdschrift voor geneeskunde 2001;145(25):1192-3.
2001: Reinout van Crevel; W C M de Lange; N A Vanderpuye; Dick Van Soolingen; J A A Hoogkamp-Korstanje; K M van Deuren; Bart Jan Kullberg; C van Herwaarden; Jos W M van der Meer
The impact of nontuberculous mycobacteria on management of presumed pulmonary tuberculosis.
Infection 2001;29(2):59-63.
2001: MA Schouten; Rob Willems; W A Kraak; Janetta Top; J A A Hoogkamp-Korstanje; Andreas Voss
Molecular analysis of Tn1546-like elements in vancomycin-resistant enterococci isolated from patients in Europe shows geographic transposon type clustering.
Antimicrobial agents and chemotherapy 2001;45(3):986-9.
2000: MA Schouten; J A A Hoogkamp-Korstanje; Jacques Meis; Andreas Voss
Prevalence of vancomycin-resistant enterococci in Europe.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(11):816-22.
2000: J A A Hoogkamp-Korstanje; H Moesker; G A Bruyn
Ciprofloxacin v placebo for treatment of Yersinia enterocolitica triggered reactive arthritis.
Annals of the rheumatic diseases 2000;59(11):914-7.
2000: J A A Hoogkamp-Korstanje; J Roelofs-Willemse
Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates.
The Journal of antimicrobial chemotherapy 2000;45(1):31-9.
1999: MA Schouten; Andreas Voss; J A A Hoogkamp-Korstanje
Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group.
Antimicrobial agents and chemotherapy 1999;43(10):2542-6.
1998: P T Odinot; Jacques Meis; J A A Hoogkamp-Korstanje; Willem J G Melchers
In situ localisation of Yersinia enterocolitica by catalysed reported deposition signal amplification.
Journal of clinical pathology 1998;51(6):444-9.
1998: C M A Swanink; V M Stolk-Engelaar; Jos W M van der Meer; JH Vercoulen; Gijs Bleijenberg; JF Fennis; Jochem M D Galama; J A A Hoogkamp-Korstanje
Yersinia enterocolitica and the chronic fatigue syndrome.
The Journal of infection 1998;36(3):269-72.
1998: P T Odinot; Jo H A J Curfs; Jacques Meis; Willem J G Melchers; J A A Hoogkamp-Korstanje
Local expression of cytokine mRNA in spleen and Peyer's patches of rats is involved in resistance against infection with Yersinia enterocolitica.
Cytokine 1998;10(3):206-12.
1997: C M A Swanink; Andreas Voss; J A A Hoogkamp-Korstanje
[Infections in elderly patients].
Nederlands tijdschrift voor geneeskunde 1997;141(45):2159-62.
1997: Jo H A J Curfs; Jacques Meis; J A A Hoogkamp-Korstanje
A primer on cytokines: sources, receptors, effects, and inducers.
Clinical microbiology reviews 1997;10(4):742-80.
1997: J A A Hoogkamp-Korstanje
In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
The Journal of antimicrobial chemotherapy 1997;40(3):427-31.
1997: MA Schouten; J A A Hoogkamp-Korstanje
Comparative in-vitro activities of quinupristin-dalfopristin against Gram-positive bloodstream isolates.
The Journal of antimicrobial chemotherapy 1997;40(2):213-9.
1997: MA Schouten; Andreas Voss; J A A Hoogkamp-Korstanje
VRE and meat.
Lancet 1997;349(9060):1258.
1997: P E Verweij; D Bijl; Willem J G Melchers; B E De Pauw; Jacques Meis; J A A Hoogkamp-Korstanje; Andreas Voss
Pseudo-outbreak of multiresistant Pseudomonas aeruginosa in a hematology unit.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1997;18(2):128-31.
1996: Paul E Verweij; F Smedts; T Poot; P Bult; J A A Hoogkamp-Korstanje; Jacques Meis
Immunoperoxidase staining for identification of Aspergillus species in routinely processed tissue sections.
Journal of clinical pathology 1996;49(10):798-801.
1996: Andreas Voss; Willem J G Melchers; D Bijl; J A A Hoogkamp-Korstanje; Jacques Meis
Staphylococcus epidermidis catheter-related infections in a short-bowel patient. Persistence of a single strain over a two-year period.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1996;17(10):669-71.
1996: Paul E Verweij; Jacques Meis; Jacqueline Sarfati; J A A Hoogkamp-Korstanje; Jean-Paul Latgé; Willem J G Melchers
Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis.
Journal of clinical microbiology 1996;34(10):2595-7.
1996: S B Debast; Jacques Meis; W J Melchers; J A A Hoogkamp-Korstanje; Andreas Voss
Use of interrepeat PCR fingerprinting to investigate an Acinetobacter baumannii outbreak in an intensive care unit.
Scandinavian journal of infectious diseases 1996;28(6):577-81.
1996: V M Stolk-Engelaar; J A A Hoogkamp-Korstanje
Clinical presentation and diagnosis of gastrointestinal infections by Yersinia enterocolitica in 261 Dutch patients.
Scandinavian journal of infectious diseases 1996;28(6):571-5.
1995: Paul E Verweij; Jean-Paul Latgé; Antonius J M M Rijs; Willem J G Melchers; B E De Pauw; J A A Hoogkamp-Korstanje; Jacques Meis
Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies.
Journal of clinical microbiology 1995;33(12):3150-3.
1995: V M Stolk-Engelaar; Jacques Meis; J A Mulder; F L Loeffen; J A A Hoogkamp-Korstanje
In-vitro antimicrobial susceptibility of Yersinia enterocolitica isolates from stools of patients in The Netherlands from 1982-1991.
The Journal of antimicrobial chemotherapy 1995;36(5):839-43.
1995: A Zakrzewska-Bode; H L Muytjens; Kian Liem; J A A Hoogkamp-Korstanje
Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters.
The Journal of hospital infection 1995;31(3):189-93.
1995: Jo H A J Curfs; Jacques Meis; J A Fransen; H A van der Lee; J A A Hoogkamp-Korstanje
Interactions of Yersinia enterocolitica with polarized human intestinal Caco-2 cells.
Medical microbiology and immunology 1995;184(3):123-7.
1995: P T Odinot; Jacques Meis; P J Van den Hurk; J A A Hoogkamp-Korstanje; Willem J G Melchers
PCR-based characterization of Yersinia enterocolitica: comparison with biotyping and serotyping.
Epidemiology and infection 1995;115(2):269-77.
1995: J A A Hoogkamp-Korstanje; V M Stolk-Engelaar
Yersinia enterocolitica infection in children.
The Pediatric infectious disease journal 1995;14(9):771-5.
1995: Jo H A J Curfs; Jacques Meis; H A Van der Lee; J A Mulder; W A Kraak; J A A Hoogkamp-Korstanje
Persistent Yersinia enterocolitica infection in three rat strains.
Microbial pathogenesis 1995;19(1):57-63.
1995: Paul E Verweij; D Stynen; Antonius J M M Rijs; B E de Pauw; J A A Hoogkamp-Korstanje; Jacques Meis
Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients.
Journal of clinical microbiology 1995;33(7):1912-4.
1995: Paul E Verweij; Antonius J M M Rijs; B E De Pauw; Alphons Horrevorts; J A A Hoogkamp-Korstanje; Jacques Meis
Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis.
Journal of clinical pathology 1995;48(5):474-6.
1995: J A A Hoogkamp-Korstanje; Jacques Meis; J Kissing; J van der Laag; Willem J G Melchers
Risk of cross-colonization and infection by Pseudomonas aeruginosa in a holiday camp for cystic fibrosis patients.
Journal of clinical microbiology 1995;33(3):572-5.
1995: J Curfs; Jacques Meis; H van der Lee; W Kraak; J A A Hoogkamp-Korstanje
Invasion of Caco-2 cells by Yersinia enterocolitica O:8 WA.
Contributions to microbiology and immunology 1995;13():251-3.
1995: V Stolk-Engelaar; Jacques Meis; J Mulder; F Loeffen; J A A Hoogkamp-Korstanje
Activity of 24 antimicrobials against Yersinia enterocolitica.
Contributions to microbiology and immunology 1995;13():172-4.
1995: V Stolk-Engelaar; J A A Hoogkamp-Korstanje
Diagnosis in Yersinia enterocolitica infection.
Contributions to microbiology and immunology 1995;13():137-9.
1995: P T Odinot; Jacques Meis; P J van den Hurk; J A A Hoogkamp-Korstanje; Willem J G Melchers
PCR-based DNA fingerprinting discriminates between different biotypes of Yersinia enterocolitica.
Contributions to microbiology and immunology 1995;13():93-8.
1995: P E Verweij; Alex Van Belkum; Willem J G Melchers; Andreas Voss; J A A Hoogkamp-Korstanje; Jacques Meis
Interrepeat fingerprinting of third-generation cephalosporin-resistant Enterobacter cloacae isolated during an outbreak in a neonatal intensive care unit.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1995;16(1):25-9.
1994: Willem J G Melchers; Paul E Verweij; P van den Hurk; Alex Van Belkum; B E De Pauw; J A A Hoogkamp-Korstanje; Jacques Meis
General primer-mediated PCR for detection of Aspergillus species.
Journal of clinical microbiology 1994;32(7):1710-7.
1993: G P Bongaerts; J A A Hoogkamp-Korstanje
In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.
Antimicrobial agents and chemotherapy 1993;37(9):2017-9.
1993: Jacques Meis; C Festen; J A A Hoogkamp-Korstanje
Pyosalpinx caused by Streptococcus pneumoniae in a young girl.
The Pediatric infectious disease journal 1993;12(6):539-40.
1990: R P Mouton; J Hermans; A M Simoons-Smit; J A A Hoogkamp-Korstanje; J E Degener; B van Klingeren
Correlations between consumption of antibiotics and methicillin resistance in coagulase negative staphylococci.
The Journal of antimicrobial chemotherapy 1990;26(4):573-83.
1983: J A A Hoogkamp-Korstanje; J van der Laag
Piperacillin and tobramycin in the treatment of Pseudomonas lung infections in cystic fibrosis.
The Journal of antimicrobial chemotherapy 1983;12(2):175-83.
1980: J A A Hoogkamp-Korstanje; J van der Laag
Incidence and risk of cross-colonization in cystic fibrosis holiday camps.
Antonie van Leeuwenhoek 1980;46(1):100-1.